Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Other Non-Current Assets: 2019-2024

Historic Other Non-Current Assets for Eton Pharmaceuticals (ETON) over the last 6 years, with Dec 2024 value amounting to $12,000.

  • Eton Pharmaceuticals' Other Non-Current Assets rose 58.33% to $19,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $19,000, marking a year-over-year increase of 58.33%. This contributed to the annual value of $12,000 for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from FY2024, Eton Pharmaceuticals' Other Non-Current Assets is $12,000, which was down 0.00% from $12,000 recorded in FY2023.
  • In the past 5 years, Eton Pharmaceuticals' Other Non-Current Assets ranged from a high of $40,000 in FY2020 and a low of $12,000 during FY2022.
  • For the 3-year period, Eton Pharmaceuticals' Other Non-Current Assets averaged around $12,000, with its median value being $12,000 (2024).
  • Data for Eton Pharmaceuticals' Other Non-Current Assets shows a maximum YoY crashed of 47.50% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Eton Pharmaceuticals' Other Non-Current Assets stood at $40,000 in 2020, then crashed by 47.50% to $21,000 in 2021, then slumped by 42.86% to $12,000 in 2022, then remained steady at $12,000 in 2023, then remained steady at $12,000 in 2024.